ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,963Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 6969

$679K Total Retail Price of All Prescriptions

Rank: 310 out of 6969

992 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 992 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 992 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,780 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 1,014 861 1 2
LOVASTATIN 843 741 2 15
HYDROCODONE-ACETAMINOPHEN 719 490 S3 3 3
OMEPRAZOLE 697 528 4 6
SIMVASTATIN 652 501 5 1
METFORMIN HCL 625 499 6 7
HYDROCHLOROTHIAZIDE 501 395 7 8
ATENOLOL 489 392 8 9
LEVOTHYROXINE SODIUM 451 357 9 5
FUROSEMIDE 401 342 10 10
AMLODIPINE BESYLATE 356 319 11 4
WARFARIN SODIUM 338 320 12 20
GABAPENTIN 289 194 13 17
POTASSIUM CHLORIDE 279 230 14 30
TERAZOSIN HCL 243 225 15 49
SERTRALINE HCL 239 201 16 38
LOSARTAN POTASSIUM 213 175 17 12
TRIAMTERENE-HCTZ 202 163 18 58
GLYBURIDE 189 166 R 19 54
GEMFIBROZIL 186 129 20 85
ZOLPIDEM TARTRATE 177 110 21 16
METOPROLOL SUCCINATE 175 153 22 22
PAROXETINE HCL 174 123 23 65
GLIPIZIDE 173 138 24 21
IBUPROFEN 165 96 25 29
ALENDRONATE SODIUM 164 117 26 14
METOPROLOL TARTRATE 159 133 27 13
FLUOXETINE HCL 141 82 28 43
FLUTICASONE PROPIONATE 128 99 29 24
CLONIDINE HCL 128 80 29 59
CARVEDILOL 123 98 31 25
DIGOXIN 119 108 32 71
TRAMADOL HCL 116 70 33 27
RANITIDINE HCL 114 68 34 46
ATORVASTATIN CALCIUM 114 110 34 11
LANTUS 112 38 36 50
BENAZEPRIL HCL 111 85 37 18
DONEPEZIL HCL 107 107 38 32
CEPHALEXIN 103 76 39 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 91 40 28
VERAPAMIL ER 99 98 40 133
CLOPIDOGREL 98 92 42 48
NAPROXEN 97 70 43 62
PROAIR HFA 95 58 44 33
INSULIN SYRINGE 91 57 45 60
DILTIAZEM 24HR CD 90 82 46 191
CIPROFLOXACIN HCL 89 69 47 64
TAMSULOSIN HCL 89 76 47 23
TRAZODONE HCL 88 27 49 47
TRIAMCINOLONE ACETONIDE 88 59 49 55
CYCLOBENZAPRINE HCL 87 45 R 51 130
PLAVIX 86 75 52 68
KLOR-CON 10 85 54 53 160
CITALOPRAM HBR 83 62 54 34
DILTIAZEM 24HR ER 80 72 55 183
KLOR-CON 8 80 70 55 104
ADVAIR DISKUS 78 54 57 45
ALLOPURINOL 78 78 57 35
ACETAMINOPHEN-CODEINE 76 46 S3 59 73
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 51 60 114
PREMARIN 72 60 R 61 156
ATENOLOL-CHLORTHALIDONE 71 66 62 262
ENALAPRIL MALEATE 68 41 63 56
FINASTERIDE 68 68 63 80
CARISOPRODOL 67 0 R 65 69
BACLOFEN 67 44 65 86
DOXAZOSIN MESYLATE 66 64 67 74
FAMOTIDINE 64 33 68 37
BUPROPION HCL SR 64 38 68 195
PROPRANOLOL HCL 63 47 70 153
PRAVASTATIN SODIUM 61 35 71 19
OXYBUTYNIN CHLORIDE 56 52 72 126
DILTIAZEM ER 55 34 73 206
DIOVAN 55 51 73 26
VENTOLIN HFA 55 27 73 125
KLOR-CON M10 52 49 76 257
LOSARTAN-HYDROCHLOROTHIAZIDE 51 49 77 53
MORPHINE SULFATE ER 51 30 S2 77 90
PREMPRO 50 38 R 79 496
PANTOPRAZOLE SODIUM 50 40 79 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.